Ocular Therapeutix Inc.

NASDAQ: OCUL · Real-Time Price · USD
12.60
-0.05 (-0.40%)
At close: Aug 15, 2025, 3:59 PM
12.80
1.59%
After-hours: Aug 15, 2025, 07:10 PM EDT

Ocular Therapeutix Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
13.46M 10.63M 17.08M 15.43M 16.44M 14.71M 14.8M 14.95M 15.19M 13.37M 14.08M 11.96M 12.27M 13.19M 12.31M 12.15M 11.72M 7.34M
Cost of Revenue
1.94M 1.26M 1.23M 1.56M 1.51M 1.33M 1.39M 1.38M 1.3M 1.21M 1.01M 1.07M 1.16M 1.3M 1.11M 1.31M 1.1M 892K
Gross Profit
11.52M 9.37M 15.85M 13.86M 14.93M 13.39M 13.42M 13.57M 13.88M 12.16M 13.06M 10.89M 11.11M 11.89M 11.2M 10.84M 10.62M 6.45M
Operating Income
-67.64M -63.92M -50.58M -46M -43.59M -31.62M -20.05M -19.21M -20.57M -22.55M -19.36M -21.54M -19.92M -17.83M -18.05M -19.53M -20.23M -20.23M
Interest Income
3.46M 3.83M 4.67M 5.65M 6.04M 3.92M 1.46M 1.21M 748K 563K 423K 285K 73K 18K 6K 7K 8K 12K
Pretax Income
-67.81M -64.05M -48.39M -36.49M -43.78M -64.85M -29.22M -516K -20.68M -30.32M -15.54M -24.19M -18.77M -12.54M -3.85M 2.66M -8.48M 3.12M
Net Income
-67.81M -64.05M -48.39M -36.49M -43.78M -64.85M -29.22M -516K -20.68M -36.4M -11.72M -26.83M -17.62M -7.25M -5.53M 2.66M -8.48M 3.12M
Selling & General & Admin
28.07M 30.5M 25.44M 22.81M 29.66M 24.33M 17.27M 17.9M 19.36M 19.96M 18.88M 18.72M 17.93M 16.62M 16.67M 17.65M 16.99M 15.75M
Research & Development
51.08M 42.86M 40.99M 37.05M 28.86M 20.73M 16.2M 15.02M 15.09M 14.75M 13.54M 13.72M 13.1M 13.1M 12.58M 12.72M 13.86M 10.93M
Other Expenses
n/a n/a n/a n/a n/a n/a 1K n/a n/a -1K n/a 1K n/a -2K n/a n/a 1K n/a
Operating Expenses
79.16M 73.35M 66.43M 59.86M 58.52M 45.06M 33.47M 32.92M 34.45M 34.71M 32.42M 32.44M 31.03M 29.72M 29.25M 30.37M 30.85M 26.68M
Interest Expense
3.02M -2.98M 3.11M 3.22M 3.2M 4.05M 4.15M 3.43M 1.99M 1.77M 1.85M 1.8M 1.7M 1.68M 1.68M 1.66M 1.66M 1.68M
Selling & Marketing Expenses
13.73M 14.15M 10.84M 10.57M 9.99M 10.18M -26.48M 9.31M 11.15M 10.84M 10.53M 10.19M 10.14M 9.06M 9.14M 9.58M 8.39M 8.09M
Cost & Expenses
81.1M 74.61M 67.66M 61.42M 60.03M 46.39M 34.85M 34.3M 35.76M 35.92M 33.44M 33.51M 32.18M 31.02M 30.36M 31.68M 31.95M 27.57M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 6.08M -3.82M 2.64M -1.15M -5.29M 1.68M n/a n/a n/a
Shares Outstanding (Basic)
172.59M 169.4M 168.02M 166.99M 165.82M 132.02M 84.43M 79.37M 78.05M 77.39M 77.01M 76.98M 82.53M 82.51M 76.62M 76.55M 76.32M 76.07M
Shares Outstanding (Diluted)
172.59M 169.4M 168.02M 166.99M 165.82M 132.02M 84.43M 85.14M 78.05M 77.39M 77.01M 76.98M 82.53M 82.51M 82.39M 85.45M 82.09M 87.25M
EPS (Basic)
-0.39 -0.38 -0.29 -0.22 -0.26 -0.49 -0.35 -0.01 -0.26 -0.47 -0.15 -0.35 -0.21 -0.09 -0.07 0.03 -0.11 0.04
EPS (Diluted)
-0.39 -0.38 -0.29 -0.22 -0.26 -0.49 -0.35 -0.01 -0.26 -0.47 -0.15 -0.35 -0.21 -0.09 -0.07 -0.23 -0.1 -0.24
EBITDA
-63.77M -63.92M -44.33M -32.31M -39.63M -59.88M -24.11M -18.32M -18.04M -28.07M -13.2M -21.88M -16.52M -10.3M -1.6M -18.93M -6.21M -19.58M
EBIT
-64.8M -67.04M -45.28M -33.27M -40.58M -60.8M -25.07M 2.91M -18.69M -28.55M -13.7M -22.39M -17.07M -10.86M -2.17M 4.32M -6.83M 4.8M
Depreciation & Amortization
1.03M 3.12M 951K 959K 956K 920K 958K 890K 652K 483K 491K 509K 552K 557K 570K 594K 611K 646K